Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, Caballero T, Farkas H, Grumach A, Kaplan AP, Riedl MA, Triggiani M, Zanichelli A, Zuraw B, HAWK under the patronage of EAACI (European Academy of Allergy and Clinical Immunology): Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014, 69: 602-616. 10.1111/all.12380.
CAS
Article
PubMed
Google Scholar
Bork K, Meng G, Staubach P, Hardt J: Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006, 119: 267-274. 10.1016/j.amjmed.2005.09.064.
Article
PubMed
Google Scholar
Farkas H: Current pharmacotherapy of bradykinin-mediated angioedema. Expert Opin Pharmacother. 2013, 14: 571-586. 10.1517/14656566.2013.778826.
CAS
Article
PubMed
Google Scholar
Frank MM, Gelfand JA, Atkinson JP: Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976, 84: 580-593. 10.7326/0003-4819-84-5-580.
CAS
Article
PubMed
Google Scholar
Bouillet L, Longhurst H, Boccon-Gibod I, Bork K, Bucher C, Bygum A, Caballero T, Drouet C, Farkas H, Massot C, Nielsen EW, Ponard D, Cicardi M: Disease expression in women with hereditary angioedema. Am J Obstet Gynecol. 2008, 199: 484-10.1016/j.ajog.2008.04.034. e481-484
Article
PubMed
Google Scholar
Pappalardo E, Zingale LC, Cicardi M: Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol. Immunol Lett. 2003, 86: 271-276. 10.1016/S0165-2478(03)00029-4.
CAS
Article
PubMed
Google Scholar
Drouet C, Désormeaux A, Robillard J, Ponard D, Bouillet L, Martin L, Kanny G, Moneret-Vautrin DA, Bosson JL, Quesada JL, López-Trascasa M, Adam A: Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. J Allergy Clin Immunol. 2008, 121: 429-433. 10.1016/j.jaci.2007.10.048.
CAS
Article
PubMed
PubMed Central
Google Scholar
Fust G, Farkas H, Csuka D, Varga L, Bork K: Long-term efficacy of danazol treatment in hereditary angioedema. Eur J Clin Invest. 2011, 41: 256-262. 10.1111/j.1365-2362.2010.02402.x.
CAS
Article
PubMed
Google Scholar
Shahidi NT: A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin Ther. 2001, 23: 1355-1390. 10.1016/S0149-2918(01)80114-4.
CAS
Article
PubMed
Google Scholar
Gelfand JA, Sherins RJ, Alling DW, Frank MM: Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med. 1976, 295: 1444-1448. 10.1056/NEJM197612232952602.
CAS
Article
PubMed
Google Scholar
Zurlo JJ, Frank MM: The long-term safety of danazol in women with hereditary angioedema. Fertil Steril. 1990, 54: 64-72.
CAS
PubMed
Google Scholar
Cicardi M, Castelli R, Zingale LC, Agostoni A: Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol. 1997, 99: 194-196. 10.1016/S0091-6749(97)70095-2.
CAS
Article
PubMed
Google Scholar
Sloane DE, Lee CW, Sheffer AL: Hereditary angioedema: Safety of long-term stanozolol therapy. J Allergy Clin Immunol. 2007, 120: 654-658. 10.1016/j.jaci.2007.06.037.
CAS
Article
PubMed
Google Scholar
Bork K, Bygum A, Hardt J: Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann Allergy Asthma Immunol. 2008, 100: 153-161. 10.1016/S1081-1206(10)60424-3.
CAS
Article
PubMed
Google Scholar
Farkas H, Czaller I, Csuka D, Vas A, Valentin S, Varga L, Széplaki G, Jakab L, Füst G, Prohászka Z, Harmat G, Visy B, Karádi I: The effect of long-term danazol prophylaxis on liver function in hereditary angioedema-a longitudinal study. Eur J Clin Pharmacol. 2010, 66: 419-426. 10.1007/s00228-009-0771-z.
CAS
Article
PubMed
Google Scholar
Szegedi R, Szeplaki G, Varga L, Prohaszka Z, Szeplaki Z, Karadi I, Fust G, Farkas H: Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients. Atherosclerosis. 2008, 198: 184-191. 10.1016/j.atherosclerosis.2007.09.025.
CAS
Article
PubMed
Google Scholar
Szeplaki G, Varga L, Valentin S, Kleiber M, Karadi I, Romics L, Fust G, Farkas H: Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol. 2005, 115: 864-869. 10.1016/j.jaci.2004.12.1130.
CAS
Article
PubMed
Google Scholar
Zuraw BL: Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new?. Ann Allergy Asthma Immunol. 2008, 100: S13-S18. 10.1016/S1081-1206(10)60581-9.
CAS
Article
PubMed
Google Scholar
Cicardi M, Bergamaschini L, Cugno M, Hack E, Agostoni G, Agostoni A: Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. J Allergy Clin Immunol. 1991, 87: 768-773. 10.1016/0091-6749(91)90120-D.
CAS
Article
PubMed
Google Scholar
Zuraw BL, Busse PJ, White M, Jacobs J, Lumry W, Baker J, Craig T, Grant JA, Hurewitz D, Bielory L, Cartwright WE, Koleilat M, Ryan W, Schaefer O, Manning M, Patel P, Bernstein JA, Friedman RA, Wilkinson R, Tanner D, Kohler G, Gunther G, Levy R, McClellan J, Redhead J, Guss D, Heyman E, Blumenstein BA, Kalfus I, Frank MM: Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med. 2010, 363: 513-522. 10.1056/NEJMoa0805538.
CAS
Article
PubMed
Google Scholar
Porebski G, Reshef A, Moldovan D: The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: who will take advantage of the individualized treatment approach?. Allergy. 2013, 68: 1207-1209.
CAS
Article
PubMed
Google Scholar
Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, Aygoeren-Pürsün E, Craig T, Binkley K, Hebert J, Ritchie B, Bouillet L, Betschel S, Cogar D, Dean J, Devaraj R, Hamed A, Kamra P, Keith PK, Lacuesta G, Leith E, Lyons H, Mace S, Mako B, Neurath D, Poon MC, Rivard GE, Schellenberg R, Rowan D, Rowe A, et al: 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010, 6: 24-10.1186/1710-1492-6-24.
Article
PubMed
PubMed Central
Google Scholar
Craig T, Aygören-Pürsün E, Bork K, Bowen T, Boysen H, Farkas H, Grumach A, Katelaris CH, Lockey R, Longhurst H, Lumry W, Magerl M, Martinez-Saguer I, Ritchie B, Nast A, Pawankar R, Zuraw B, Maurer M: WAO Guideline for the Management of Hereditary Angioedema. World Allergy Organ J. 2012, 5: 182-199. 10.1097/WOX.0b013e318279affa.
Article
PubMed
PubMed Central
Google Scholar